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The cartilage matrisome in adolescent idiopathic scoliosis
Carol A. Wise 1,2,3,4, Diane Sepich5, Aki Ushiki6,7, Anas M. Khanshour1, Yared H. Kidane1, Nadja Makki8, Christina A. Gurnett9,10,11,
Ryan S. Gray12, Jonathan J. Rios1,2,3,4, Nadav Ahituv6,7 and Lila Solnica-Krezel5
The human spinal column is a dynamic, segmented, bony, and cartilaginous structure that protects the neurologic system and
simultaneously provides balance and flexibility. Children with developmental disorders that affect the patterning or shape of the
spine can be at risk of neurologic and other physiologic dysfunctions. The most common developmental disorder of the spine is
scoliosis, a lateral deformity in the shape of the spinal column. Scoliosis may be part of the clinical spectrum that is observed in
many developmental disorders, but typically presents as an isolated symptom in otherwise healthy adolescent children. Adolescent
idiopathic scoliosis (AIS) has defied understanding in part due to its genetic complexity. Breakthroughs have come from recent
genome-wide association studies (GWAS) and next generation sequencing (NGS) of human AIS cohorts, as well as investigations of
animal models. These studies have identified genetic associations with determinants of cartilage biogenesis and development of
the intervertebral disc (IVD). Current evidence suggests that a fraction of AIS cases may arise from variation in factors involved in
the structural integrity and homeostasis of the cartilaginous extracellular matrix (ECM). Here, we review the development of the
spine and spinal cartilages, the composition of the cartilage ECM, the so-called “matrisome” and its functions, and the players
involved in the genetic architecture of AIS. We also propose a molecular model by which the cartilage matrisome of the IVD
contributes to AIS susceptibility.
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INTRODUCTION
The human spine serves multiple structural and physiologic roles.
An essential function of the spinal column in all vertebrates is to
integrate the brain and nervous system with the axial skeleton and
simultaneously protect the spinal cord. For humans, the symmetry
and position of the spine is key for bipedalism and for maintaining
the center of gravity over the pelvis.1 The spine, with its 33
vertebrae, 23 intervertebral discs (IVDs), ligaments, and facet
joints, withstands biomechanical forces while providing flexibility
in three dimensions (Fig. 1). The stability of this multicomponent
system over a lifetime is remarkable, although eventually the wear
and tear from environmental stresses, plus genetic contributions,
can evoke degenerative changes primarily in the IVD of the
lumbar spine.2 Other common pathologies of the adult spine
include tumors, fractures, lumbar spondylosis, stenosis, and
segmental instability or deformity. Scoliosis is a lateral spinal
deformity that is common and exhibits increasing prevalence with
age and degeneration of the spine.3 In children, rare develop-
mental disorders of embryogenesis due to malformed vertebrae,
muscle weakness, or neurologic impairment can affect the
integrity of the spine.1 However, the most frequent spinal disorder
presenting in children is idiopathic scoliosis, which unlike adult
scoliosis occurs in the absence of other associated pathologies or
degenerative changes. Idiopathic scoliosis, defined by lateral
deformity greater than 10 degrees on coronal radiographs, usually
presents during the adolescent growth spurt. Adolescent idio-
pathic scoliosis (AIS) is the most common pediatric musculoske-
letal disorder, occurring in ~3% of school age children, >29 million
children worldwide4 (Fig. 2). Untreated, progressive AIS is
associated with restrictive lung disease, pain, and severe deformity
later in life.5 Although curve patterns vary, right-sided thoracic
deformities are typical for reasons that are not understood. A child
whose scoliosis continues to worsen before the peak of growth
velocity is at greatest risk of serious deformity, but after skeletal
maturity the risk of “curve progression” decreases sharply.6
Orthotics, i.e., a back bracing, may be prescribed to help control
progression until skeletal maturity, and not to necessarily correct
existing deformity.7,8 Bracing is considered to have “failed” if the
curve continues to progress to ~50 degrees before closure of
growth plates as measured from iliac crest or hand X-rays.9 In this
scenario, the standard of care is surgical correction, with the goal
of reducing the deformity, fusing the involved vertebral bodies to
prevent continued progression, and achieving balance of the
head, shoulders, and trunk over the pelvis. Typical surgery involves
implanting metal instrumentation to provide the forces to
straighten and derotate the deformity.1
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For centuries, physicians have speculated on the causes of AIS.10
In what tissues does it originate, and why the curious onset during
the adolescent growth spurt? Case reports and epidemiologic
studies dating back more than 45 years have consistently
demonstrated significant but complex heritability in AIS.11–13 The
assumption from these models is that AIS, in a typical patient,
arises from a cumulative effect of several to many genetic risk
factors. Certain patients, however, may harbor more deleterious
genetic factors, for example, those with a family history of the
disease, that increase their risk of developing a scoliosis
phenotype. Another curious feature of AIS is its striking sexual
dimorphism, with girls having a more than fivefold greater risk
than boys of progressive deformity requiring treatment.14 These
observations suggest that the genetic factors underlying AIS may
differ between the sexes. In this model, it is hypothesized that the
total mutational burden required to “activate” progressive AIS in
males will be greater than that in females, a phenomenon known
as the Carter effect.15,16 It follows from this concept that males with
progressive AIS will harbor more high-risk, deleterious mutations.
As with other complex genetic disorders, we expect many heritable
mutations with varying effect sizes and frequencies will comprise
the total mutational burden in AIS. Variants that are rare in a
population tend to be more penetrant and confer a greater disease
risk in an individual, whereas common variants are expected to be
less penetrant and to confer relatively smaller effects.17
The underlying genetic, molecular, and cellular causes of AIS
have remained enigmatic for centuries. However, modern
genomic and systems biology approaches in human patient
cohorts are beginning to elucidate the genetic changes under-
lying AIS risk. Simultaneously, precise and powerful forward and
reverse genetic approaches in vertebrate model systems are
enabling researchers to rapidly identify new AIS candidate genes
that may be screened in clinical cohorts, as well as to directly test
the phenotypic and mechanistic consequences of mutations
discovered in human patients. From these efforts the field of AIS
research has seen a convergence on factors that control the
development of the IVD, particularly on molecules that maintain
or comprise the extracellular matrix (ECM). For the rest of this
review, we focus on the biologic factors that control IVD
development and their genetic contributions to AIS susceptibility.
We also discuss the implications of these discoveries for new
hypothesis-driven research and therapeutic interventions.
BIOLOGIC PATHWAYS OF SPINE DEVELOPMENT
The diverse functions of the spine in strength, flexibility, balance,
and protection are enabled by a striking segmented organization
along the vertical axis that is the product of an exquisitely
controlled molecular network called the “segmentation clock”. The












Fig. 1 The human spine viewed from the back (posterior) and side (lateral)
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number of excellent reviews to which we refer the reader.18,19
Briefly, in early development, presomitic mesodermal cells
proliferate and move from the tail bud at a specific rhythmic
pace, creating somites that emerge at the anterior tip and progress
along the embryonic axis (Fig. 3). The somites then develop into a
dorsal epithelial dermomyotome that differentiates into skin and
muscle, and a ventral sclerotome that forms the vertebral bodies,
ribs, tendons, and cartilages of the spine, i.e., the vertebral growth
plates and IVDs. In humans, a pair of somites forms every 6–12 h
between days 20 and 32 of embryonic development.20 This finely
timed process is controlled by three major signaling pathways—
Fibroblast Growth Factor (FGF), Notch, and Wnt/β-catenin—that
set up waves of gene expression through “circuits” controlling the
timing of oscillations, spatial expression, and synchronicity of
somitogenesis.18,21 The subsequent formation of the sclerotome,
i.e., future spine and associated structures, requires that a subset of
mesodermal cells in the ventral somite region undergo an
epithelial-to-mesenchymal transition and then migrate toward
the midline to surround the notochord (axial mesoderm). This two-
step transition is regulated by Wnt and Fgf signaling pathways.22
The vertebrate spine also derives from the axial mesoderm in
addition to the paraxial mesoderm (somites) (Fig. 3).
DEVELOPMENTAL REGULATION OF IVD BIOGENESIS
In early mouse embryonic development, the sclerotome migrates
out from the somites to surround the notochord in a pattern of
condensed and less condensed segments corresponding to future
IVD and vertebral bodies, respectively, along the anterior/posterior
axis. The paired box 1 (Pax1) transcription factor is a well-described
marker of sclerotome development which is induced via factors
secreted from the notochord including: Sonic Hedgehog (Shh) and
through noggin-dependent inhibition of bone morphogenetic
protein (BMP) signaling.23 During embryonic spine development,
the notochord regresses from regions of developing vertebral
bodies and expands in regions of the future IVD (Fig. 3). The
mechanism of this physical transformation of the notochord
remains unresolved but may be related to the mechanical force
exerted by the developing vertebral bodies.23–25 Eventually, the
notochord tissue gives rise to the nucleus pulposus (NP), the gel-
like inner core of the IVD, and Pax1 expressing cells contribute to
the region of the outer annulus fibrosus (AF) IVD.26 The
spontaneous mutant mouse strains “undulated” and “scoli” display
varying spinal phenotypes resulting from mutations in the Pax1
locus.27–30 Two undulated strains (un, Unex) exhibit mild kink tail
phenotypes due to hypomorphic Pax1 mutations. By comparison,
the homozygous Uns/Uns strain harbors a 120 kb deletion
encompassing Pax1 and completely lacks lower thoracic and
lumbar vertebral units. Of note, Uns/Uns displays a more severe
phenotype than a homozygous targeted knockout of Pax1,
suggesting that noncoding sequences outside of Pax1 may drive
expression of additional loci related to spine development. Indeed,
analysis of Pax1 enhancers using transgenic assays in mouse
identified a strong extra-genic enhancer “Xe1” which drives
expression in the sclerotome and whose loss presumably
contributes to the Uns/Uns phenotype.31 More comprehensive
analysis of enhancers, using transcriptomic and chromatin
immunoprecipitation sequencing (ChIP-seq) studies of Pax1-
positive flow-sorted E12.5 vertebral column cells, found enrich-
ment of signals at loci related to ECM, cartilage development, and
collagen fibrillogenesis biological pathways. Moreover, Pax1-
negative cells display a general downregulation of ECM genes,
e.g., Col11A1, suggesting Pax1 is a critical transcriptional regulator
of ECM matrix biogenesis in the outer AF. Proteoglycan accumula-
tion (e.g., aggrecan) is also significantly reduced in animals lacking
Pax1.32,33 It is clear from these and other studies that Pax1,
together with its paralog Pax9, act synergistically to drive
development of IVD of the entire vertebral spine.34
Sox9 is a master transcriptional regulator of chondrogen-
esis.33,35–38 Sox5/6 is expressed in the notochord and the
sclerotome, where they share partially redundant roles and
cooperate with Sox9 to drive the expression of chondrogenesis
genes in the growth plate.39–44 Sox5 and 6 are clearly important in
IVD development as well. Both are expressed in the notochord
and the sclerotome, and the notochordal sheath fails to form in
Sox5−/−;Sox6−/− mice. The consequence of this is failure of the NP
to form. In addition to severe chondrodysplasia, mice lacking Sox6
alone develop a kinked tail that occurs in segments where the NP
is small and misplaced,43,45 while Sox5−/−;Sox6−/− double mutant
mice display a virtual absence of cartilage and chondrogenic
tissues of the spine.46 Other striking features of Sox5−/−;Sox6−/−
double mutant mice are the downregulation of genes encoding
major ECM components including collagen II, aggrecan, and
cartilage link protein, and a general delay in differentiation of the
inner AF (IAF).32,45,47 Sox9 controls Sox5/6 expression and is
required for the normal patterning and development of the spine,
Fig. 2 Adolescent idiopathic scoliosis in a female patient. Photograph and standing radiograph (left) reveal a typical right-sided thoracic curve
and postural imbalance that is largely corrected with surgical implants (right)
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failing to generate obvious patterned vertebral bodies or IVD
tissues when ablated in embryonic mice.48 Sox9 is continuously
required for homeostasis of the spine in adult mice, where its
ablation in skeletally mature mice leads to kyphoscoliosis, disc
compression, and degeneration of the IVD.37 Interestingly, Pax1
transcripts are upregulated when Sox5 and 6 together are
removed genetically from the IVD anlagen, suggesting regulatory
feedback between Sox5/6 and Pax1 signaling, which may help to
define the regulatory programs driving development of the inner
and outer AF. Indeed, Pax1, as well as its paralog Pax9, also assists
in the robust gene expression of Sox5. Thus, Pax1/9 and Sox9
function in concert with BMP and transforming growth factor
(TGF) signaling and are critical to initiate expression of chondro-
genic genes during early IVD differentiation. Later, the expression
of Pax1 is restricted to the outer annulus by the Sox5/Sox6
negative feedback mechanism26,49 (Fig. 4).
BEARING THE LOAD—THE POSTNATAL INTERVERTEBRAL DISC
In humans, the spine grows most rapidly in the first 5 years of life,
with an average T1 to S1 segment length increase of 10 cm during
this time (2 cm per year). There is a slower T1 to S1 growth from
age 5 to 10 years of ~5 cm until adolescence (1 cm per year). From
age 10 years to adulthood, T1 to S1 grows an additional 10 cm;
this includes the adolescent growth spurt (2 cm per year).50 There
are 23 IVDs in the fully formed human spine that collectively
contribute about one third of its height.51 The vertebrate IVD is
composed of fibrocartilaginous tissues encapsulating a gel-like NP
tissue, and consequently is considered a cartilaginous tissue joint
that connects the vertebral bodies (Fig. 5a). Cells within the IVD
are described as “chondrocyte-like” and “fibroblast-like”. Within
the IVD, the NP is surrounded by a lamellar structure aptly named
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Fig. 3 Cartoon depiction of the stages of somitogenesis and maturation of the intervertebral disc. Somites (lavender) become epithelialized
to form the dermomyotome (red) and sclerotome. Cells of the sclerotome migrate from pairs of paraxial somites and condense around the
notochord in a characteristic pattern of more or less condensed regions. These alternating regions (blue and lavender in the figure) give rise
to the vertebral bodies and AF, respectively. The NP arises by a different developmental path by swelling in the region of the IVD and pinching
off of the notochord in the vertebral bodies
Chondrogenic mesenchymal cells Pre-chondrocytes
Sox9 Sox6, 5L, 9
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Fig. 4 Schematic of the Pax/Sox-mediated extracellular matrix
pathway in cartilages and IVD. Genes that have been associated
with AIS are shown in bold. Pax1 expression precedes expression of
the Sox trio in IVD development. The Sox trio directly activates the
transcription of many ECM genes. Gpr126 and Sox9 positively
regulate each other in IVD and chondrocyte cells. In the presence
of Sox9, Pax1/9 may inhibit expression of aggrecan and possibly
other ECM genes in a context-dependent manner
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the AF. The ring-shaped AF has two distinct parts, an inner AF
made of chondrocytic cells nearest the NP and expressing type II
collagen, and an outer AF made of fibroblast-like cells expressing
mostly type I collagen. In the outer AF, concentric lamellae of
collagen fibers are organized in alternating angles that are oblique
to the spinal axis, a so-called “angle-ply” structure. This arrange-
ment conveys mobility and flexibility in multiple planes of
motion.23,52 The IVD is capped by the cartilage endplate (CEP)
that connects to cartilage fibers extending from the AF.
The CEP has the critical role of supplying oxygen and nutrients
to cells within the IVD, which is in fact the largest avascular
structure in the body (Fig. 5a). While the cells of the outer AF are
fed by capillaries in the surrounding soft tissues, the remaining
cells of the AF and NP receive their nutrients from capillaries that
penetrate the vertebral bodies and terminate in loops within the
CEP. Nutrients and metabolites then move to and from cells of the
disc through the CEP and dense ECM, mostly by diffusion. The IVD
is relatively acellular, with about 9 000 “fibroblast-like” cells per
mm3 in the AF and only 4 000 “chondrocyte-like” cells per mm3 in
the NP.52 In the latter case, notochordal-like cells that begin as
large vacuolated structures are slowly replaced by distinctly
smaller and less metabolic cells in postnatal development, up to
~10 years of age in humans (Fig. 5b). At this point, notochordal-
like cells are virtually absent and replaced by cells with a
chondrocyte-like morphology.23 The transition of cells to a
chondrocyte-like phenotype coincides with a change in ECM
composition and firming of the NP due to collagen fibril
accumulation. The precise transition states of the cells within
the NP, and underlying mechanism driving their phenotypes, are
still unclear. Cell-tracing experiments using specific Cre drivers
such as Shh-Cre and Noto-Cre demonstrate that cells of
notochordal origin are detected in adult NP cells of the mouse.24
However, not all cells are labeled in these experiments, pointing to
heterogeneity that could be due to spatio-temporal differences in
NP cell content or even differing origins. Clearly a key role of the
NP is to orchestrate the production of healthy ECM.53 Experi-
mental evidence suggests that the large notochordal-like
“precursor” cells produce proteoglycans faster than small
chondrocyte-like cells. Moreover, the distribution and assembly
of proteoglycans differs between the two cell types.54 Conse-
quently, it is reasonable to conjecture that the proportions of cell
types within the NP may determine ECM production and thereby
influence the strength and integrity of the IVD.
COMPOSITION AND ROLE OF THE INTERVERTEBRAL DISC
MATRISOME
In the intact disc, osmotic swelling within the NP is resisted radially
by the collagen fibers of the AF and axially by the endplates and
vertebrae. The AF then effectively absorbs compressive and
torsional loads.23,52 Thus, the three components of the disc are
“greater than the sum of the parts”, serving to support and
maintain each other as they collectively bear loading of the spine
while conferring mobility. Deficiencies in any one part of the disc
can impact the whole and, in the mature organ, lead to irreversible
damage. The ECM is a critical functional compartment of the IVD,
providing mechanical strength, regulating nutritional flow as
noted, and conveying physiologic signals back to the cells55 (Fig. 6).
The composition of the acellular ECM, the so-called “matrisome”
has been described in a number of excellent reviews to which we
direct the reader.56–58 Here we describe the ECM in brief, with
particular reference to the cartilaginous matrisome of the IVD.
Predominant components of the cartilage matrisome are fibrillar
collagens, chondroitin sulfate proteoglycans, and hyaluronic acid.
These large molecules form the basic structural network of the
matrisome that allows other factors and cells to interact.56,58 The
IVD produces multiple collagens including types I, II, III, V, VI, IX, XI,
XII, and XIV. Types I and II collagens are predominant in the AF and
NP, respectively as noted. The minor, less abundant collagen types
V and XI form hybrid fibrils with types I and II collagens,
respectively, where they are thought to help maintain an
appropriately narrow diameter to the collagen fibrils in each
compartment. Proteomic studies of the bovine NP suggest that















Fig. 5 The human IVD. The IVD is largely avascular, receiving nutrition through the cartilaginous endplate. Callout depicts replacement/
conversion of notochordal-like cells in the nucleus pulposus with chondrocyte-like cells in the first 10 years of life
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type V/XI collagen pool of the disc. What determines this
composition is not clear, but may devolve from preferences of
the different C-propeptide domains of the various procollagen
chains, their relative expression levels in the endoplasmic reticulum
where the helices are formed, and/or differences in cell phenotype
within the NP both spatially and temporally, for example
chondrocytes versus notochordal cells.59 While collagen is the
primary structural component of the disc ECM, elastin fibers are
also key for structural support and resistance to deformation.51,57
The proteoglycan content is highest in the NP and declines
outward toward the AF. In the NP, chondroitin sulfate-linked
proteoglycans interact with collagens to retain hydration and form
a gel-like matrix that resists compression and provides height to
the disc. The predominant proteoglycan of the IVD matrisome is
aggrecan, present in both NP and AF.23 Aggrecan is aptly named
as it aggregates along chains of hyaluronan, a high molecular
weight polysaccharide, through a small “link” protein called
cartilage link protein.60 The overall negative charge of this
complex attracts water and leads to osmotic swelling within the
loose meshwork of collagen fibrils in the NP23,51,61 (Fig. 6).
Aggrecan is composed of a core protein linked to both
chondroitin sulfate and keratan sulfate chains. Chondroitin sulfate
is the major side chain at birth, but over time the proportion of
keratan sulfate substitution increases. The shift in side chain
composition of aggrecan seems to mirror the transition of
notochordal-like cells to chondrocyte-like cells and may reflect
differing aggrecan production by the two cell types and less
access to oxygen that is needed for chondroitin sulfation
intermediates.52,53 Hyaluronan and link protein also change in
abundance over time in the disc. While hyaluronan increases, link
protein abundance decreases with age and its proteolytic
processing increases. There is evidence that a peptide called “N-
link” released by this process actually stimulates ECM (glycosami-
noglycan and collagen) production via BMP2 receptor SMAD1/
5 signaling.62,63
Other proteoglycans in the disc function as accessory proteins
that may, for example, participate in collagen assembly and help
to regulate the appropriate width and length of fibrils. For
example, small leucine-rich repeat proteins (SLRPs) are proteogly-
cans such as versican, decorin, biglycan, fibromodulin, lumican,
and perlecan that contain characteristic domains including
carboxy-terminal leucine-rich repeats (Fig. 6). These proteins
regulate collagen fibril growth rates, size, content, and width.56
Other proteins effectively bridge the structural components of the
ECM, re-enforcing and strengthening the network and also
connecting it to cells and to other soluble factors. The multi-
domain structures of these connectors facilitate direct binding to
cell surface receptors, other ECM connectors, and soluble growth
factors. Example glycoproteins in this class include the fibronec-
tins and laminins. Like collagens, laminins are triple-helical
proteins made up of α, β, and γ chains that combine via a central
coiled-coil domain. Multifunctional domains of the laminins can
interact with cell surface receptors such as integrins and also other
components of the ECM, thereby mediating cell–cell interactions.
Fibronectin, a large secreted glycoprotein, dimerizes through
C-terminal disulfide bonds where it binds to collagens, gelatins,
integrins, and other ECM molecules. In particular, fibronectin
binding to integrin receptors promotes their clustering in the cell
membrane, which in turn leads to further assembly of fibronectin
into fibrils around the cells.56–58 In the adult disc, fibronectin
proteolysis into fragments is correlated with the grade of disc
degeneration, and has been shown to stimulate catabolic events
that lead to the same.52
ORGANIZATION OF THE IVD MATRISOME
Within the disc, the AF is a collagen-rich fibrillar ECM constructed
to withstand tensile and torsional forces transmitted outward from
the gelatinous NP. Microfibrils are an important structure distinct
from collagen and elastin fibrils.51,57 The primary structural
component of microfibrils in the IVD are the large, structurally
distinctive fibrillin glycoproteins (FBN1, 2, 3). Associated with the
fibrillins are a number of ancillary proteins, such as microfibril-























Fig. 6 Cartoon depiction of a cartilage cell and surrounding matrix. Fibrillar collagens are shown in pink, while sulfated proteoglycan (e.g.
aggrecan, perlecan) is shown as a complex with link protein and hyaluronic acid. The adhesion G protein receptor GPR126 is depicted
interacting with a laminin ligand, although its physiologic interaction in cartilage has not been described
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the OAF and IAF microfibrils co-localize with elastin fibers. While in
the OAF microfibrils closely align with collagen lamellae of the
ECM, in the IAF fibrillin-positive microfibrils are also seen in an
elastin-negative region around cells. In the NP microfibrils are
found almost exclusively in the pericellular region, away from
elastin fibers in the ECM.51 The distribution of microfibrils may
reflect differing roles in the OAF, which must absorb the brunt of
compression and torsional forces, compared with the IAF and NP
that are subjected to relatively minor, isotropic forces. It is also
now appreciated that the microfibrillar niche is a command center
for regulating cellular behavior. This is apparently achieved
through direct interactions with cell surface receptors as well as
by serving as a reservoir for various growth factors, particularly in
the TGF family.51,64,65
PATHWAYS OF IVD DEVELOPMENT AND SUSCEPTIBILITY TO
ADOLESCENT IDIOPATHIC SCOLIOSIS
The majority of genetic risk in AIS has been defined thus far by
hypothesis-free genome-wide association studies (GWAS) that
map the location of genetic risk factors in the genome relative to
fixed markers, usually single nucleotide polymorphisms (SNPs).66
By definition, SNPs are common in the population and conse-
quently can be informative in statistical tests such as logistic
regression that measure frequency differences between affected
cases and matched controls. Because of the many tests performed
in a typical GWAS (so-called “multiple testing”), a significance level
of P < 5 ×10−8 is generally required for any association to be
declared significant (GWAS-level significance). Replication of
GWAS-significant loci is necessary to independently validate
candidate SNPs and provide realistic estimates of effect size and
fraction of risk conferred across populations. It is important to
note that while GWAS are proven to be powerful for mapping
disease loci, further fine-mapping approaches are needed to
define the underlying causal mutations. Multiple AIS risk loci that
were originally identified in GWAS have been further validated
by replication and meta-analysis studies, as given in Table 1.
Importantly, while these studies have mapped disease loci near or
within likely candidate genes, the majority have not pinpointed
causal sequence changes driving genetic associations. None-
theless, as shown below, the number of validated loci around
genes that are known to determine early spine development is
striking. Further, pathway enrichment analysis of a recent multi-
ethnic GWAS meta-analysis provided statistically significant
evidence that biologic processes of cartilage development and/
or maintenance are impacted in AIS.67
An association distal to the PAX1 gene was originally discovered
by a GWAS in 3 102 individuals of European descent (North
American) and replicated in independent North American,
Japanese, and East Asian female cohorts.68 Further investigation
revealed that the association was driven almost entirely by
females (combined rs6137473 P= 2.15 × 10−10, OR= 1.30) but not
males (combined rs6137473 P= 0.71, OR= 1.08), identifying it as
an apparently sex-specific AIS locus. Resequencing highly
conserved sequence elements within the associated interval in
AIS subjects refined the signal to a putative enhancer near the Xe1
Table 1. Susceptibility loci in AIS. Table of significant associations and OMIM-related phenotypes
Genome region Marker Candidate gene(s) OMIM disorder Reference
10q24.31 rs11190870 LBX1 59
6q24.1 rs6570507 GPR126 Lethal congenital contracture syndrome 61
9p22.2 rs3904778 BNC2 76
20p11.22 rs6137473 PAX1 Otofacial cervical syndrome 2 42
9q34.2 rs687621 ABO 68
11p15.2 rs1455114 SOX6 Craniofacial dyssynostosis with short stature 68
16q23.3 rs4513093 CDH13 68
18q21.33 rs4940576 BCL2 62
2q36.1 rs13398147 PAX3/EPHA4 Craniofacial-deafness-hand syndrome 62
1p36.32 rs241215 AJAP1 62
17q24.3 rs12946942 SOX9, KCNJ2 Campomelic dysplasia/familial atrial fibrillation 60
11q24.1 rs35333564 MIR4300HG 68
4q21.23 rs141903557 LOC101928978 111
1q21.2 rs11205303 MTMR11 96
1q42.13 rs12029076 ARF1 96
22q11.21 rs1978060 TBX1 Velocardiofacial syndrome 96
12p12.3 rs2467146 LINC02378/MIR3974 96
8p23.2 rs11787412 CSMD1 96
9p13.3 rs188915802 KIF24 96
6q14.1 rs658839 BCKDHB/FAM46A Osteogenesis imperfecta type XVIII 96
7p15.1 rs160335 CREB5 96
6q22.1 rs482012 NT5DC1 96
7p22.3 rs11341092 LOC101927021/UNCX 96
1q32.2 rs17011903 PLXNA2 Beckwith–Wiedemann syndrome 96
7p21.2 rs397948882 AGMO/MEOX2 96
16q12.2 rs12149832 FTO Growth retardation, developmental delay, and facial dysmorphism 96
Regions in the human genome providing statistically significant evidence of harboring an AIS risk factor are denoted by their OMIM locus number (column
one) where applicable. The markers shown are those that provided most significant evidence in the region
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enhancer described earlier. The new enhancer, called PEC7, was
shown to drive reporter gene expression in zebrafish somites, an
activity that was disrupted by AIS-associated SNPs.68 These data
suggest that alterations in the spatial and/or temporal control of
PAX1 expression can increase risk of spinal deformity (AIS). The
association signal within an intron of the SOX6 gene implicates its
transcriptional regulation in AIS. SOX6 is expressed in several
tissues including testis, muscle, and spinal cord in addition to
chondrocytes.45 However, it is tempting to speculate that AIS-
associated variation in the SOX6 enhancer could specifically
diminish its expression in cartilaginous tissues and thus dysregu-
late SOX5/6/9, PAX1, and possibly even GPR126 (see below) in
these tissues. GPR126 (OMIM 612243, alias ADGRG6, or VIGR) is a
member of the adhesion G protein-coupled receptor family with
multiple cellular functions ranging from cell adhesion to migra-
tion, to name a few.69 In humans, GPR126 is highly expressed in
cartilages and the IVD. In mouse embryo, Gpr126 is highly
expressed in the proliferating cartilage of the spine, suggesting its
role in spinal development could be exerted through effects on
chondrogenesis.70 As outlined below, further experiments in
conditional mutants have supported this hypothesis, and in
particular, have shown that Gpr126 is a positive regulator of
cartilage differentiation and possibly its homeostasis. In the
chondrogenic ATDC5 cell line, Gpr126 mRNA expression increases
with early chondrogenic differentiation.71 Gpr126 overexpression
in this cell line increases expression of the cartilage marker genes
Col2a1 (encoding type II collagen) and Acan (encoding aggrecan),
while Gpr126 knockdown decreases their expression.72 Gpr126
and Sox9 are also positive regulators of each other, as knockdown
or knockout of either reduces expression of the other in ATDC5
cells, chondrocytic N1511 cells, or adult IVD.37,72 In zebrafish,
Gpr126 is required for Schwann cell myelination, an effect that
could be overcome by elevating cAMP levels with forskolin,
suggesting a classic signaling mechanism through G proteins.73
Gpr126 receptor signaling can be self-activated through autopro-
teolytic processing.74 Gpr126 additionally mediates certain activ-
ities such as Schwann cell development through interaction with a
laminin-211 ligand.75 However, the mechanisms by which
Gpr126 signals in chondrocyte cells are yet to be characterized.
Whether genetic variation of other associated loci contributes
to mechanisms of cartilage biogenesis awaits investigation. For
example, CDH13 encodes the cadherin 13, or “T-cadherin” protein,
a unique member of the cadherin family that lacks transmem-
brane and cytoplasmic domains, attaching to the plasma
membrane via a glycosylphosphatidylinositol anchor.76 During
development T-cadherin is highly expressed throughout the early
developing sclerotome, with later expression restricted to the
caudal sclerotome and migrating neural crest cells.77 Strong
CDH13 expression is also reported in a chondrocytic cell line and
rib cartilage, but its role in these tissues is unknown.67 ABO
encodes glycosyltransferase isoforms that catalyze the transfer of
carbohydrates to the H antigen, forming the antigenic structures
of the ABO blood group [MIM:616093]. ABO is expressed at varying
levels in a variety of tissues and is reportedly undetected in
cartilage. BNC2 (OMIM 608669) encoding Basonuclin 2, is a highly
conserved transcription factor belonging to the C2H2 group of
zinc finger proteins. In humans, BNC2 is produced in a variety of
tissues including bone and cartilage. The strongest and most
reproduced association with AIS in multiple studies is with SNP
rs11190870 that is located near the end of the LBX1 gene. LBX1 is
encoded head-to-head with another gene FLJ41350 (also called
LOC399806 or LBX1-AS1 (for LBX1 antisense RNA 1)). LBX1 (OMIM
604255) encodes the ladybird late homeobox transcription factor.
Lbx1 is specifically expressed early in embryogenesis in the
developing dermamyotome and is suggested to control the
expression of genes that guide lateral migration of muscle
precursors and maintain their migratory potential.78 Lbx1 is also
critical for specification of dorsal interneuron fates and
somatosensory function.79 Thus, LBX1 may be implicated in
myogenic and neurogenic etiology of human AIS.
GENETICS OF AIS CURVE PROGRESSION
Identifying patients with a high likelihood of curve progression is a
top priority of AIS clinical management. Consequently, a
comprehensive search for severity-correlated SNPs was conducted
in a GWAS by limiting cases to those with spinal deformity above
40 degrees after skeletal maturity or surgical correction. Through a
two-stage association study using a total of 12 000 Japanese
subjects, a novel locus, rs12946942 on chromosome 17q24.3,
showed significant association and was replicated in a Han
Chinese population.80 rs12946942 and the LD block containing it
are in a gene desert between SOX9 and KCNJ2. The block contains
six enhancer elements, one of which forms a long-range
chromatin loop to SOX9 in a prostate cancer cell line, and SNPs
within the enhancer appear to direct allele-specific gene expres-
sion. It is posited that variants in the region may confer significant
risk of progressive AIS by controlling scoliosis-related spatio-
temporal SOX9 expression.
A later study in the Japanese cohort identified association with
SNPs in MIR4300HG, the gene encoding MIR4300 microRNA.
Correlated SNPs were mapped within a putative enhancer in a
conserved toplogically associated domain (TAD). So-called TADs
are large, self-interacting genomic regions that are implicated in
gene regulation.81 Although MIR4300 expression has been noted
in bone, cartilage, IVD, and spinal cord among other tissues, its
function and potential role in AIS is not yet known.82
THE IVD MATRISOME AND RARE GENETIC VARIATION
Heritability studies (calculated as the square of the correlation
coefficient, r2) estimate that <7% of the total genetic variance
underlying AIS has been discovered.67 More recently, DNA
sequence-based approaches have been applied to both AIS
case/control cohorts and to individual AIS families, with the goal
of identifying rare disease-causing variants that would be missed
by standard GWAS and that could account for “missing”
heritability.83 The discovery of rare disease alleles has been
bolstered by large-scale publicly available reference sets such as
the Genome Aggregated Database (gNOMAD) that provide
summary data for sequenced alleles.84 The search space for rare
genetic risk factors is often limited to the exons of the genome,
the so-called “exome” for practical reasons, e.g., cost, computation
time, and biologic interpretability. As the costs of sequencing
decrease, the field is moving beyond exome sequencing (ES)
toward genome sequencing (GS). Simultaneously, the tools for
identifying and interpreting noncoding rare disease variants are
rapidly improving.85 Single rare variants may be tested for
enrichment in cases versus controls or co-segregation with
disease in families. Alternatively, a potentially more informative
approach is to statistically measure the burden of rare alleles per
gene (i.e., coding sequences) in cases versus controls. The first ES
burden study of 91 AIS cases and 337 controls showed FBN1 and
FBN2, encoding fibrillins-1 and -2, respectively, as the most
significantly associated genes. Dominantly inherited mutations in
FBN1 are known to cause Marfan syndrome (OMIM 154700).
Marfan syndrome patients typically present with distinctive
skeletal features including increased height, disproportionately
long limbs and digits, anterior chest deformity, mild-to-moderate
joint laxity, scoliosis, dural ectasia (widening of the dural sac
around the spinal cord), and a narrow, highly arched palate with
crowding of the teeth. Cardiovascular features can be life-
threatening and include mitral valve prolapse, mitral regurgitation,
dilatation of the aortic root, and aortic regurgitation.86 Mutations
in FBN2 are associated with the related disorder Congenital
Contractural Arachnodactyly (CCA) (OMIM 121050). The mutations
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identified in AIS tended to be associated with tall stature and
larger spinal curves, but without the cardiac manifestations or
other complications that are typical of MFS or CCA,87 suggesting
they exert hypomorphic effects on the functions of these proteins.
Other sequence-based studies have highlighted rare mutations
in ECM genes. In a pathway-based analysis of severe (i.e. >40
degree curves) AIS, restricting the analysis to novel (not found in
dbSNP at that time) coding variants revealed association with
musculoskeletal collagen genes, particularly COL11A2.88 Dominant
inheritance of mutations in COL11A1, COL11A2, and COL2A1 cause
Stickler or Marshall syndromes (OMIM 604841, 184840, 154780).
The Stickler/Marshall syndromes are hereditary conditions char-
acterized by distinctive, flattened facial features, abnormalities of
the vitreous, conductive hearing loss, scoliosis or kyphosis, and
joint problems including joint hypermobility and early onset
arthritis. Many Stickler patients exhibit Pierre Robin sequence, a
combination of features (cleft palate, glossoptosis, micrognathia)
that can lead to feeding problems and difficulty breathing.89,90 On
average, significantly more novel variants in ECM genes were
observed in the AIS cohort compared with controls, suggesting
that the polygenic accumulation of novel variants within
potentially many ECM genes contributes to AIS risk. More recently,
an exome-wide association study that was restricted to severe AIS
identified a variant in the SLC39A8 gene. SLC39A8 is a ubiquitously
expressed divalent metal cation transporter that, not surprisingly,
has been genetically linked to disorders of numerous organ
systems in humans including blood pressure, body mass index
(BMI), circulating manganese levels, and circulating cholesterol
levels.91 The AIS-associated variant altered alanine at position 391
to threonine. This single amino acid change was also correlated
with greater spinal curvature, decreased height, increased BMI,
and lower plasma manganese in AIS cases. Mutations in the
zebrafish homolog caused vertebral anomalies and mild spinal
curvatures that were noted to be reminiscent of zebrafish
knockouts of the gene encoding alpha-1 chain of type VIII
collagen described below.92 This observation suggests the
possibility of a functional interaction between Slc39a8 and the
extracellular matrix in zebrafish, and possibly other vertebrates
including humans. Taken together, rare variant-based studies are
interpreted to suggest that rare, hypomorphic variants in genes
responsible for Mendelian connective tissue disorders may be
contributing factors in AIS.
Families with multiple affected members provide the opportu-
nity to map and identify disease variants by their co-segregation
with AIS. In one study, filtering for rare variants (minor allele
frequency <5% in the Exome Aggregation Consortium (EXAC))
identified by ES in five multigenerational families followed by gene
ontology term enrichment analyses produced top results for actin-
and microtubule-based projections and ECM.93 In a separate
hypothesis-driven study, the HSPG2 gene encoding the SLRP
perlecan was selected as a candidate per ES of an extended AIS
family. One particular HSPG2 variant, Asn786Ser, was marginally
overrepresented in a larger case-control cohort.94 Recessively
inherited mutations in the HSPG2 gene cause Schwartz–Jampel
syndrome type I (OMIM 255800), a rare disorder characterized by
joint contractures, myotonic myopathy (muscle stiffness), dystro-
phy of epiphyseal cartilages, eye abnormalities, short stature,
distinct facial features and propensity to malignant hyperthermia.95
In a separate study, linkage analysis and ES of a Swedish pedigree
with an autosomal dominant inheritance of AIS identified a rare,
nonsynonymous variant (V2287I) in the CELSR2 gene encoding
cadherin EGF LAG seven-pass G-type receptor 2. Furthermore,
analysis of tagging SNPs revealed significant association
(P= 0.000 1) to this variant in a set of 1 739 Swedish-Danish AIS
cases and 1 812 controls but not with case-control cohorts from
Japan and the US. It is interesting to note that CELSR2 is a planar
cell polarity cadherin, like GPR126, that encodes an adhesion-class
G protein receptor. Mice that lack Celsr2 develop progressive
hydrocephalus and display dysgenesis of ependymal cilia. Further
family-based studies hold promise for discovering higher-impact
AIS disease alleles, although reduced penetrance of the phenotype
is an acknowledged challenge. Continued genome sequencing in
both populations and families is warranted to fully define the
polygenic architecture of the disease.
MODELS OF AIS PATHOGENESIS
Taken together, evidence from human genetic studies and animal
models supports a role for vertebral cartilages, particularly the
cartilage matrisome, in AIS pathogenesis. This model focuses
attention on the IVD due to its role in withstanding and dissipating
the forces of spinal growth. Radiographic studies of the spine in
patients with progressive scoliosis are consistent with this model.
In AIS patients that were followed longitudinally, wedging of the
involved discs preceded wedging of the involved vertebrae until
the end of the growth spurt, at which point vertebral wedging
progressed somewhat more.96 Furthermore, MRI studies of AIS
patients found that progressive scoliosis was associated with
displacement of the NP toward the convexity of the curve.96
Whether the relatively subtle hypomorphic genetic changes in
components of the IVD ECM identified with AIS so far are necessary
or sufficient to cause AIS is not clear at present. Consequently, the
ability to affect spatio-temporal expression of specific genes with
precision, and to create knock-ins of disease-associated mutations
in vertebrate models will be key for addressing these questions.
The specific tissues in which AIS originates has been difficult to
discern, as bone and soft tissue components of the spine in
human patients appear to develop and function normally, at least
superficially. Likewise, although AIS manifests around the adoles-
cent growth spurt, it has been unclear whether its origins trace
back to deficiencies in early development. Research addressing
these questions has been severely limited by a lack of appropriate
animal models that recapitulate a true AIS phenotype. This issue is
likely a reflection of several factors, including reduced penetrance
and the relatively late onset that may be missed in typical forward
genetic screens. Moreover, the genetic factors identified in
humans thus far point to hypomorphic mutations and variations
in regulatory elements that may manifest in tissue- and temporal-
specific ways. Fortunately, breakthroughs in this regard have come
from use of the Cre/loxP system to create tissue-specific and
inducible knockouts of AIS candidate genes. For example,
removing Gpr126 using a Col2Cre driver produced thoracic
scoliosis beginning at age P20 and becoming more prevalent
with age. From this study it was posited that AIS may arise from
deficiencies in a specific osteoprogenitor cell type expressing type
II collagen.97 The study also suggested that scoliosis may have its
beginnings in early development. While cell proliferation was
unaffected in rib and spinal cartilage (IVD) cells, a slight increase in
apoptotic cells was noted in both locations at P1 before the
expected onset of spinal curvature. This and additional experi-
ments defined a critical role for Gpr126 on cartilage development,
including effects on the morphogenesis of the annulus fibrosis,
chondrocyte survival, and the expression of Gal3st4 encoding
galactose-3-O-sulfotranserase 4.98 These results also support the
hypothesis that the dysregulation, and possibly loss, of specific cell
populations early in postnatal development leads to a “weakened”
IVD, perhaps through deficiencies in the ECM, that is vulnerable to
the increasing axial and torsional forces exerted during rapid
growth.
Fish (teleosts) are emerging as powerful tools for understanding
developmental mechanisms of spinal deformities. Scoliotic curves
have been observed in various fish species, including early studies
in “curveback” guppy that demonstrated a heritable phenotype
reminiscent of human idiopathic scoliosis.99 It has been con-
jectured that the cranial to caudal spinal loads that fish experience
while swimming may recapitulate, to some extent, the same
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directional forces on the human spine due to walking upright.100
Zebrafish (Danio rerio) in particular is a workhorse laboratory fish
that has become a staple in the armamentarium of tools to dissect
human developmental disorders. Attractive features of the
zebrafish include its relatively rapid generation time of 6–12 weeks,
external and near-transparent development, and genetic and
genomic tractability. Early models of spinal deformity in zebrafish
were mapped to mutations in the Col8a1a gene encoding alpha-1
chain of collagen type VIII. These mutants exhibited vertebral
anomalies, reminiscent of human “congenital” scoliosis, that were
correlated with early defects of notochord development.101
Similar morphologic changes were later noted in Slc39a8 knockout
zebrafish as described above, raising the question of a possible
pathogenic overlap between congenital scoliosis that involves
frank vertebral anomalies, and idiopathic scoliosis in which the
vertebrae appear to be morphologically normal. Evidence in
support of this came from another gene-targeting study in
zebrafish that produced the first genetically defined develop-
mental model of IS. In that study, genetic removal of an atypical
protein tyrosine kinase called Ptk7 evoked a rotational spinal
deformity beginning at late larval stages and progressing until
sexual maturity. This model also recapitulates human IS in that
there was a strong bias toward severe curves in females. Further
genetic manipulations that removed maternal copies of Ptk7 in
early development led to loss-of-function mutants with vertebral
anomalies reminiscent of congenital scoliosis, suggesting that the
same genetic mutations could result in idiopathic versus
congenital scoliosis phenotypes in a context-dependent man-
ner.102 This study of ptk7 mutants implicated abnormal spinal fluid
flow. A more recent study further implicated neuroinflammation
as an underlying cause of spine curve formation in ptk7
mutants.103 A correlation between inflammation and onset of
scoliosis was also supported by independent studies in which the
transcription factor Stat3 was removed from maternal and zygotic
zebrafish. During later development, stat3 mutant zebrafish
exhibit stunted growth, scoliosis, excessive inflammation, and fail
to thrive. In humans, dominant-negative mutations in STAT3 cause
Hyper IgE syndrome marked by dysregulation of immunity as well
as late-onset scoliosis reminiscent of AIS.104
The ability to create knock-ins of specific human mutations,
whether in exons or in disease-associated enhancers such as Xe1/
PEC7, using genome editing tools will be critical for hypothesis-
testing in vertebrate systems. It remains to be seen whether single
variants in individual genes will be sufficient to create AIS-like
phenotypes in mouse. More likely, in keeping with the complex
heritability of AIS, it may be combinations of genetic changes
affecting multiple components of the cartilage matrisome that will
be required to evoke progressive deformity. The introduction of
multiple genetic changes into individual animals by breeding
strategies or sequential genome editing may be required to model
AIS appropriately.
THERAPEUTIC STRATEGIES FOR AIS
Natural-history studies have shown AIS measuring less than 30
degrees at the cessation of growth rarely increases in adulthood.
Fortunately, the majority of patients are in this category but
nevertheless require careful monitoring with radiography to monitor
the curve. Curves greater than 50 degrees, however, will slowly
progress throughout adulthood at a rate of 0.75–1.00 degrees per
year. Therefore, the AIS patient with an immature skeleton and
scoliosis of greater than about 20 degrees is at risk for progression
and may be treated by bracing.14 Bracing addresses both biologic
and biomechanical susceptibility in AIS by relieving asymmetric
loading in the spine and thereby allowing symmetric growth.
Although bracing has shown efficacy in preventing progression in
clinical trials,8 it is typically prescribed to be worn 12–16 h each day
over a course of years, and compliance is notoriously poor.8,105
Surgical correction is required when bracing fails to halt progression,
not only to address the appearance of the deformity but also to
prevent future pulmonary complications. Lung volume normally
increases dramatically during the juvenile and adolescent years,
approximately doubling from the age of 10 years to skeletal
maturity. Progressive AIS is associated with diminished lung
volumes, particularly for curves ≥70 degrees. Patients with curves
reaching 100 degrees are at significant risk of symptomatic
restrictive pulmonary disease. Given all of these issues, the first
goal of surgical approaches to AIS is to halt progression beyond an
acceptable limit of ~50 degrees Cobb angle, while a secondary goal
is to achieve some correction of the existing deformity.1
The fact that bracing can be successful suggests that future
biologic therapies aimed at preventing progression should target
the same “window of opportunity”. As outlined in this review,
genomic studies of human AIS point to the biogenesis and/or
maintenance of the ECM of the IVD in disease susceptibility. Future
therapies consequently could be aimed at stimulating proper ECM
production in cells of the IVD in patients with mild AIS, with the
goal of providing better biomechanical and/or biologic resistance
to asymmetric growth forces. Approaches to IVD-targeted therapy
could perhaps build upon the data armamentarium developed by
the intervertebral disc degeneration (IVDD) research community, as
well as on other successful gene therapy efforts.106–109 Therapies
proposed to stimulate ECM production in IVDD include local
delivery of growth factors or viral-based gene therapy, or adoptive
transfer of adult mesenchymal stem cells. In this regard, the
avascular nature of the IVD and its limited systemic connection
could prove advantageous for direct in vivo therapeutic delivery,
similar to the eye. Direct injection of therapeutic viral vectors has
shown such promise for correcting several inherited eye disorders
and it is now being pursued in clinical trials.108 In IVDD, increased
proteoglycan synthesis has been observed after direct injection of
adenovirus, adeno-associated virus, or lentivirus expressing Tgf-β,
latent membrane protein 1 (Lmp1), Sox9, and other factors in rabbit
models.106 Cell-based therapies would aim to replace or regenerate
resident IVD cells, likely using endogenous progenitor cells or MSCs
to increase ECM production. However, harvesting endogenous
cells would require surgery, and the cells would be predicted to
harbor the same genetic susceptibilities as resident IVD cells. The
number of resident NP cells in the IVD is expected to be at its peak
in individuals younger than 20 years of age.107 Although the
cellular status in AIS patients is not well understood, delivering
additional progenitors into the IVD environment might not prove
beneficial. Modern genome editing technologies provide another
promising line of gene therapy. Specifically, clustered regularly
interspaced short palindromic repeat (CRISPR)-associated
nucleases can be used to cleave specific sites, with subsequent
removal or replacement of targeted DNA sequences.108 The
benefits of genome editing are its simplicity and precision in
removing or correcting an offending mutation. This is particularly
relevant where simply stimulating endogenous gene expression
would not apply. For example, genome editing could be
envisioned to correct aberrant amino changes in type XI collagen
in the AIS IVD. Another advantage of CRISPR-based genome
editing is the efficiency of creating multiple genetic changes within
each targeted cell, which may be necessary for more complex
disorders such as AIS. It should be noted that while genome
editing holds promise, its clinical application to any acquired or
inherited human disorder is in its infancy until potential side effects
(off-target changes and possible leakage to germline) are fully
understood and controlled. Considering AIS, biologic therapies are
particularly attractive given the “window of opportunity” in
children with mild AIS who are apparently otherwise healthy.
Prevention of AIS altogether has been a futuristic goal but not
inconceivable given the emerging understanding of underlying
mechanisms. For some patients, improving mechanical function in
the IVD by boosting glycoprotein content and hydration early in
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life could be envisioned as a preventative strategy, perhaps by
small molecule or peptide therapies, or by better nutritional
delivery to the disc.110 In this scenario, the late onset and
ostensibly healthy metabolism in AIS could prove advantageous,
analogous to preventing osteoporosis by early calcium and
vitamin D intake. It is notable however that in the IVD, the ECM
is key in governing the rate of molecular transport through the
long pathway from the cartilaginous endplate to the relatively
sparse NP and/or AF cells. Aggrecan in particular intercalates with
the collagen framework and thereby largely determines solute
distribution and mobility.110 Clearly, appropriate in vitro and
in vivo model systems and more fundamental understanding of
the genetic, cellular, and developmental mechanisms of AIS are
needed to advance any biologic therapeutic strategies.
SUMMARY
The embryologic development of the spine is an exquisitely
controlled process both spatially and temporally. Deleterious
mutations in single genes controlling somitogenesis can lead to
rare Mendelian disorders affecting spinal integrity. Idiopathic
scoliosis, usually occurring at adolescence, is the most common
developmental disorder of the spine in children. AIS is genetically
complex, but emerging data both from GWAS and next-
generation sequencing of human AIS cohorts have highlighted a
role for determinants of cartilage biogenesis and development of
the IVD, particularly pathways controlling extracellular matrix, or
matrisome production. DNA sequence variants have been
identified that potentially alter the transcriptional regulation of
matrisome genes, or that create hypomorphic changes in protein-
coding sequences. Combinations of these variations may effec-
tively create tissue-specific alterations, with major effects on the
composition and/or organization of the IVD matrisome in cells of
both NP and AF. Cellular maturation in the NP occurs in the first
decade of life in humans and also may be a contributor to AIS. In
either scenario, impairments in the disc may cause asymmetric
responses to the strong torsional forces along the spine during
adolescent growth, leading the spine to twist away from these
forces. In contrast to the disc in adult IVD degeneration, the IVD in
AIS does not exhibit overt signs of degeneration. Given this and
the fact that current bracing therapies during the adolescent
growth spurt can be effective suggests that there is a window of
opportunity for providing biologic therapies to control or prevent
AIS and subsequent curve progression. The IVD of AIS patients
may be amenable to direct in vivo delivery of molecular or
nutritional therapies aimed at preserving its structural integrity.
These factors encourage optimism and justify continued research
to understand underlying disease mechanisms and to develop
robust model systems for in vivo testing.
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